Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U24NS120057)
U.S. Department of Health & Human Services | National Institutes of Health (U24NS120057)
U.S. Department of Health & Human Services | National Institutes of Health (1R24MH117295)
Article History
Received: 26 July 2025
Accepted: 4 November 2025
First Online: 16 December 2025
Competing interests
: Benjamin Dichter is the Founder and CEO of CatalystNeuro, a consulting company that specializes in open science in neurophysiology. The other three authors declare no competing interests.